<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Statement negatieve beslissing vergoeding Tecvayli®▼ (teclistamab) en Talvey®▼ (talquetamab) in basispakket</title>
    <link>https://www.jnj.com/innovativemedicine/netherlands/newsroom/statement-negatieve-beslissing-vergoeding-tecvayli-teclistamab-en-talvey-talquetamab-in-basispakket</link>
    <description>Statement negatieve beslissing vergoeding Tecvayli®▼ (teclistamab) en Talvey®▼ (talquetamab) in basispakket</description>
    <language>nl-NL</language>
    <lastBuildDate>Thu, 21 May 2026 06:36:17 GMT</lastBuildDate>
    <atom:link href="https://www.jnj.com/innovativemedicine/netherlands/newsroom/statement-negatieve-beslissing-vergoeding-tecvayli-teclistamab-en-talvey-talquetamab-in-basispakket.rss" type="application/rss+xml" rel="self" />
  </channel>
</rss>
